Hyperliquid Strategies Inc 8-K

What Happened

• Hyperliquid Strategies Inc (PURR) filed an 8-K on June 26, 2026 announcing two executive compensation actions. On June 23, 2026 the company entered an Executive Placement Agreement with SBR Limited (a Hong Kong company controlled by Jeroen Nieuwkoop) to provide Mr. Nieuwkoop’s services as Chief Operating Officer; the placement term commenced June 22, 2026. On June 22, 2026 the company executed a First Amendment to the CEO employment agreement with David Schamis, effective July 1, 2026, that increases his salary and updates his bonus and equity opportunity.

Key Details

• COO placement (SBR Limited / Jeroen Nieuwkoop):
  • Base cash remuneration: $400,000 per year (subject to board review).
  • Annual discretionary bonus target: 100% of base (performance-based).
  • Equity target: $1,000,000 annual grant-date fair value (vesting annually over 3 years); two initial restricted stock unit awards (each $1,000,000 target) also granted with multi-year vesting.
  • Termination protections: if terminated without cause or for good reason outside a change-in-control, six months of base pay, six months health premium reimbursement, and accelerated vesting of 50% of outstanding equity; during a change-in-control these extend to 12 months, 100% accelerated vesting, pro‑rated bonus for the year, and outplacement services.
  • Includes customary confidentiality, non-compete during the term, and 24‑month non-solicitation provisions after termination.
• CEO amendment (David Schamis):
  • New base salary effective July 1, 2026: $600,000 per year.
  • Annual discretionary bonus target: 100% of base (performance-based).
  • Annual equity opportunity (subject to board approval): target grant-date fair value between $2,000,000 and $3,000,000 for each fiscal year beginning July 1, 2026, with vesting and performance terms to be set by the compensation committee.

Why It Matters

• These filings increase Hyperliquid’s potential cash and equity compensation commitments (higher base salaries, sizable equity award targets and severance/accelerated-vesting provisions) which could affect future compensation expense and share dilution. The COO arrangement is structured through a consultant entity controlled by the COO, and both agreements include standard confidentiality and restrictive covenants. Investors should note the effective dates, bonus and equity targets, and the enhanced severance/vesting protections tied to change-in-control periods when assessing corporate governance, compensation expense and potential dilution.